The cardiovascular digital solutions market has seen considerable growth due to a variety of factors.
• The market size of cardiovascular digital solutions has seen robust growth in the past few years. The market is projected to increase from $98.23 billion in 2024 to $108.04 billion in 2025, expanding at a compound annual growth rate (CAGR) of 10.0%. The previous growth can be linked to the surge in cardiovascular diseases, the uptake of telemedicine, the use of data analytics for risk forecasting, initiatives aimed at patient engagement, and remote patient monitoring.
The Cardiovascular Digital Solutions market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of cardiovascular digital solutions is anticipated to witness substantial growth in the upcoming years. The market value is projected to soar to $161.57 billion by 2029, with a 10.6%.
compound annual growth rate (CAGR). This expansion in the forecasted years can be linked to the incorporation of artificial intelligence and machine learning, the widening role of digital biomarkers, remote cardiac rehabilitation initiatives, healthcare systems' interoperability, and emphasis on real-time observation and warnings. The forecast period will reveal key trends such as the use of blockchain for secure health data management, the integration of EHRS and cardiovascular digital solutions, mobile health applications for cardiovascular management, a focus on cardiovascular rehabilitation solutions, and partnerships between technology firms and healthcare providers.
The global increase in instances of cardiovascular disease is predicted to fuel the expansion of the market for cardiovascular digital solutions. Cardiovascular diseases or CVDs refer to health complications related to the heart and blood vessels. Such issues are commonly linked with damage to the heart or blood vessels. The utilization of cardiovascular digital solutions promotes patient self-reliance by encouraging them to self-track health activities aiming to mitigate disease risk factors and enhance commitment to healthy lifestyle alterations. The employment of these digital solutions has helped reduce both the morbidity and mortality associated with cardiovascular diseases. Consequently, the surge in cardiovascular disease cases is propelling the demand for cardiovascular digital solutions. For example, according to figures revealed by the Office for Health Improvement and Disparities, a governmental department in the UK, there were slightly over 1,862,500 individuals – 3 percent of the population – diagnosed with coronary heart disease in England in 2023. Thus, the global escalation in cardiovascular diseases is fuelling the growth of the cardiovascular digital solutions market.
The cardiovascular digital solutions market covered in this report is segmented –
1) By Components: Devices, Software
2) By Services: Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs, Other Services
3) By Deployment: Cloud-Based, On-Premise
4) By End-Use: Hospitals And Clinics, Ambulatory Care Centers, Other End-Users
Subsegments:
1) By Devices: Wearable Devices, Implantable Devices, Remote Monitoring Devices
2) By Software: Cardiac Monitoring Software, Data Analytics Platforms, Telehealth Solutions, Patient Management Software
Leading the trends in the cardiovascular digital solutions market is product innovation. Key players in the market are focusing their strategies on the creation of cutting-edge products to solidify their market standing. An excellent example of this occurred in February 2023 when a US-based company, Eko Health, known for producing digital health solutions for cardiac and pulmonary conditions, unveiled the SENSORA Cardiac Disease Detection Platform. SENSORA synergizes the latest strides in applied machine learning with the stethoscope, one of the most commonly utilized medical devices. Eko has conceptualized a detection platform that has the potential to evolve as its creators develop applications for additional heart conditions. This involves using digital stethoscopes to capture and scrutinize heart sounds and electrical signals. Primarily, SENSORA incorporates reliable AI technology to identify structural murmurs which are indicative of heart valve disease. Additionally, it includes Care Pathway Analytics software providing thorough analytics and understanding of the treatment journey within the healthcare ecosystem.
Major companies operating in the cardiovascular digital solutions market include:
• iRythm Technologies Inc.
• Apple Inc.
• General Electric Company
• Uber Diagnostics Private Limited
• AlivCor Inc.
• Verily Life Sciences
• HeartFlow Inc.
• Bardy Diagnostics Inc.
• BioTelemetry Inc.
• eviCore healthcare
• Nanowear Inc
• Cardiac Insight Inc.
• Bay Labs Solutions
• Change Healthcare
• Medtronic PLC
• BenevolentAI Limited
• Cardiologs Technologies
• Cardiopulmonary Corp.
• Congenica Ltd.
• Cyient Limited
• Data4Cure Inc.
• Deep Genomics Incorporated
• DNAnexus Inc.
• Emedgene Technologies Ltd.
• Fabric Genomics Inc.
• FDNA Inc.
• Freenome Holdings Inc.
• GNS Healthcare
• IBM Watson Health
• Illumina Inc.
• Microsoft Corporation
• Niramai Health Analytix
• NVIDIA Corporation
• Omron Healthcare Co. Ltd.
North America was the largest region in the cardiovascular digital solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cardiovascular digital solutions market report during the forecast period. The regions covered in the cardiovascular digital solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa